Posts Tagged ‘Fda’

More Delay for Weekly Exenatide

(MedPage Today)– The FDA declined to accept the novel extended-release type of exenatide (Bydureon) pending further safety and also efficiency data, medication makers Amylin as well as Lilly revealed.